Our lawyers have defended clients facing federal and state investigations involving a range of substantive areas, including Foreign Corrupt Practices Act violations, securities fraud, tax fraud, insider trading, public corruption, money laundering, corporate embezzlement, and mortgage fraud.
We offer full-spectrum investigations counseling to our clients. Our attorneys have counseled domestic and multinational companies and Special Committees of the Board in structuring and executing complex internal investigations involving foreign jurisdictions. This experience allows us to maintain discipline and attention to detail in each investigation. We also draw upon a strategic global network of field investigators and established contacts to assist in our matters.
We counsel clients on all phases of FCPA compliance, investigation, and enforcement. We leverage our global network of field investigators and contacts to bolster our FCPA work and help provide our clients with advice that is both practical and current. Our lawyers have experience in defending multinational companies, mid-caps and joint ventures operating in high-risk regions, and in conducting due diligence on potential acquisition targets in emerging markets.
Our team has deep experience across the whistleblower spectrum. We represent whistleblowers and defend against them, drawing on our multi-disciplinary team to address the array of unique challenges that often arise in the whistleblower setting.
We represent clients pursuing claims under the Anti-Terrorism Act (ATA), currently serving as investigative counsel in Atchley et al. v. AstraZeneca UK Ltd. et al., No. 1:17-cv-02136 (D.D.C. 2017), an ATA lawsuit against the parent companies and/or subsidiaries of AstraZeneca plc, General Electric Company, Johnson & Johnson, Pfizer Inc., and Roche Holding AG. The suit, filed on behalf of Americans who were attacked (or who have a family member who was attacked) by Shiite terrorists in Iraq, has been reported upon by the New York Times, USA Today, Fox News, NBC News, The Washington Post and other outlets. In July 2018, it was publicly reported that the Department of Justice is now “investigating claims that drug companies funded terrorism in Iraq.”
Our lawyers represent clients across the country in complex commercial disputes in federal and state trials and appeals, and in alternative dispute resolution forums such as mediation and arbitration. We routinely counsel our clients to resolve disputes without litigation. But if such efforts do not succeed, we are prepared to “go the distance” to achieve outcomes tailored to our clients’ needs and objectives.